Modalis Therapeutics Corporation
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
4883 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町三丁目１１番５号
- Website:
- https://modalistx.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Modalis Therapeutics Corporation is a biotechnology company that pioneers the development of therapeutics for genetic diseases through epigenome editing. The company's proprietary core platform, CRISPR-GNDM®, is an advanced technology designed to regulate gene expression by selectively activating or suppressing specific genes without altering the underlying DNA sequence. This system utilizes a compact editor that can be delivered to target cells via AAV vectors. Modalis operates a hybrid business model, advancing therapeutic candidates through both in-house development pipelines for subsequent licensing and collaborative partnerships. Its development pipeline is focused on addressing unmet medical needs in muscular disorders, cardiomyopathy, and central nervous system (CNS) disorders.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Modalis Therapeutics Corporation and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-14 08:48 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 237.5 KB | |
| 2025-08-14 08:31 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-08-14 08:30 |
Interim Report
半期報告書－第10期(2025/01/01－2025/12/31)
|
Japanese | 266.6 KB | |
| 2025-08-07 08:32 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 334.6 KB | |
| 2025-03-28 07:52 |
Regulatory News Service
臨時報告書
|
Japanese | 28.4 KB | |
| 2025-03-27 08:32 |
Regulatory News Service
内部統制報告書－第9期(2024/01/01－2024/12/31)
|
Japanese | 24.1 KB | |
| 2025-03-27 08:30 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-03-27 08:29 |
Annual Report
有価証券報告書－第9期(2024/01/01－2024/12/31)
|
Japanese | 2.1 MB | |
| 2025-02-21 07:31 |
Regulatory News Service
臨時報告書
|
Japanese | 21.5 KB | |
| 2024-08-13 08:14 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 293.9 KB | |
| 2024-08-13 07:58 |
Interim Report
半期報告書－第9期(2024/01/01－2024/12/31)
|
Japanese | 249.6 KB | |
| 2024-08-13 07:58 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-08-07 08:01 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 495.2 KB | |
| 2024-05-14 06:00 |
Quarterly Report
四半期報告書－第9期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 166.1 KB | |
| 2024-05-14 06:00 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB |
Automate Your Workflow. Get a real-time feed of all Modalis Therapeutics Corporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Modalis Therapeutics Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
